Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by Lifeboat1on Dec 12, 2022 11:14am
218 Views
Post# 35166124

RE:RE:RE:RE:2023 guidance

RE:RE:RE:RE:2023 guidance Qwerty22.  The Money Narrative comments tell you everything you need to know.  The Company is on the trajectory they have been saying for the past three years and have hit the first and will most likely hit the others just a little slower than initially expected.  As the article
stated, calendar 2022 revenue will exceed the forecast originally expected for 2021 and 2023 revenue will exceed the original forecast for 2022.  The important take away is the Company is on track to meet revenue guidance just a bit later than expected.  For a long that is not a problem and is just more time to buy an undervalued stock.
<< Previous
Bullboard Posts
Next >>